These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25451704)

  • 21. CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
    Ueland T; Nymo SH; Latini R; McMurray JJ; Kjekshus J; Yndestad A; Fucili A; Grosu A; Masson S; Maggioni AP; Gullestad L; Aukrust P; ;
    Eur J Heart Fail; 2013 Jul; 15(7):747-55. PubMed ID: 23487539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.
    McMurray JJ; Kjekshus J; Gullestad L; Dunselman P; Hjalmarson A; Wedel H; Lindberg M; Waagstein F; Grande P; Hradec J; Kamenský G; Korewicki J; Kuusi T; Mach F; Ranjith N; Wikstrand J;
    Circulation; 2009 Dec; 120(22):2188-96. PubMed ID: 19917888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
    Feinstein MJ; Jhund P; Kang J; Ning H; Maggioni A; Wikstrand J; Kjekshus J; Tavazzi L; McMurray J; Lloyd-Jones DM
    Eur J Heart Fail; 2015 Apr; 17(4):434-41. PubMed ID: 25684642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Ther; 2015 Dec; 33(6):338-46. PubMed ID: 26280110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
    Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
    Inglis SC; McMurray JJ; Böhm M; Schaufelberger M; van Veldhuisen DJ; Lindberg M; Dunselman P; Hjalmarson A; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
    Eur J Heart Fail; 2010 Jul; 12(7):698-705. PubMed ID: 20501489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.
    Alehagen U; Benson L; Edner M; Dahlström U; Lund LH
    Circ Heart Fail; 2015 Mar; 8(2):252-60. PubMed ID: 25575580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure.
    Lipinski MJ; Cauthen CA; Biondi-Zoccai GG; Abbate A; Vrtovec B; Khan BV; Vetrovec GW
    Am J Cardiol; 2009 Dec; 104(12):1708-16. PubMed ID: 19962481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin use in heart failure: a cause for concern?
    Raina A; Pickering T; Shimbo D
    Am Heart J; 2006 Jul; 152(1):39-49. PubMed ID: 16824830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.
    Dobre D; Rossignol P; Murin J; Parkhomenko A; Lamiral Z; Krum H; van Veldhuisen DJ; Pitt B; Zannad F
    Eur J Heart Fail; 2013 Feb; 15(2):221-7. PubMed ID: 22872593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
    Horwich TB; MacLellan WR; Fonarow GC
    J Am Coll Cardiol; 2004 Feb; 43(4):642-8. PubMed ID: 14975476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [To treat or not to treat with statins patients with chronic heart failure?].
    Hradec J
    Vnitr Lek; 2009 Sep; 55(9):802-7. PubMed ID: 19785380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.
    Nymo SH; Hulthe J; Ueland T; McMurray J; Wikstrand J; Askevold ET; Yndestad A; Gullestad L; Aukrust P
    Eur J Heart Fail; 2014 Jan; 16(1):68-75. PubMed ID: 23918775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.
    Bonsu KO; Reidpath DD; Kadirvelu A
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):177-88. PubMed ID: 26780905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    Badar AA; Perez-Moreno AC; Jhund PS; Wong CM; Hawkins NM; Cleland JG; van Veldhuisen DJ; Wikstrand J; Kjekshus J; Wedel H; Watkins S; Gardner RS; Petrie MC; McMurray JJ
    Eur Heart J; 2014 Dec; 35(48):3426-33. PubMed ID: 25265976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.